Could a simple test predict postpartum depression before it starts?
NCT ID NCT07186309
Summary
This study is testing a new device called 'Enlighten' that aims to predict a woman's risk of developing postpartum depression (PPD) before she gives birth. Researchers will enroll 1,000 pregnant women to see if analyzing biomarkers in blood or saliva samples collected at home can accurately forecast who will develop PPD within three months after delivery. The goal is to create a reliable early warning system that could help connect at-risk mothers with support sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.